PhillyPharma Archive: December, 2012

Some of J&J's McNeil brands likely joining Sanofi's Chattem, Inc.

Comment icon 0 Comments
At least on a headquarters basis, some of Johnson & Johnson's famous over-the-products could be moving from the Philadelphia suburb of... Read more

Ultimate impact of Caronia decision uncertain, but FDA and prosecutors might be more careful

Comment icon 0 Comments
Two former prosecutors say the ultimate impact of the decision in U.S. v. Caronia won't be known until further court action, but in the meantime... Read more

Flu shots and vaccine suppliers

Comment icon 0 Comments
In something of a suggestion for a New Year's resolution, the U.S. Department of Health and Human Services recommended again Wednesday that... Read more

J&J and Sanofi have pending deal on pieces of McNeil, but not Fort Washington plant

Comment icon 0 Comments
Drugmakers Johnson & Johnson and Sanofi have a pending deal involving an element of J&J’s consumer products subsidiary, McNeil... Read more

Miracles and profits in medicine and pharmaceuticals

Comment icon 0 Comments
The never-ending - and often profit-driven - hope for miraculous cures and the reality of the health-care business was displayed again over... Read more

Report: Drug stocks prey for insiders as industry resists change

Comment icon 0 Comments
A team from Bloomberg News crunched data and reported that one in five U.S. insider-trading cases involve health-care stocks. A corresponding... Read more

Federal judge dismisses Endo's suit against FDA on painkiller Opana ER

Comment icon 0 Comments
Perhaps only in the strange business of pharmaceuticals would a company sue to have a federal agency declare that one of its products was in... Read more

British ambassador would not trade health-care systems with US

Comment icon 0 Comments
Sir Peter Westmacott, the British ambassador to the United States, was in Philadelphia last week and spoke with reporters and editors from... Read more